ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI ... or AmpC-type beta-lactamases that confer resistance to third generation cephalosporins.

This Poster will be available on the Company's website on the "Publications: Posters & Presentations” page under the "Our Science” tab. ORLYNVAH™ is a novel oral penem antibiotic for ...

The poster presented at ECCMID was ... About ORLYNVAH™ ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI. ORLYNVAH™ possesses potent activity against species of ...

A student presents her research poster to Katia Del Rio Tsonis ... Brown’s research project concentrated on antibiotic resistance. Fernandes added this is a valuable opportunity for first-year ...

The poster presented at ECCMID was ... as experts raise concerns about antibiotic resistance. Iterum provides updates from the FDA's Antimicrobial Drugs Advisory Committee meeting on its NDA ...

Researchers at the University of Oxford have developed a new drug delivery system using ultrasound-activated nanoparticles to ...

A research team led by Professor Tong Zhang from the Department of Civil Engineering of Faculty of Engineering at the ...

The following is a summary of “WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, ...

More than 3 million children died from antimicrobial resistance-associated complications in 2022 across the globe, most of ...

A University of Texas Medical Branch program meant to reduce deadly infections caused by drug-resistant organisms has been designated as a Center of Excellence by the Infectious Diseases Society of ...